Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Cross-study safety analysis of risk factors in CAR T cell clinical trials: An FDA database pilot project.
Journal: Molecular therapy oncolytics
Published: February 24, 2022
FDA Approval Summary: Idecabtagene Vicleucel for Relapsed or Refractory Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 21, 2021
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 31, 2018
FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 28, 2018
Evaluation of optic neuritis following human papillomavirus vaccination.
Journal: Human vaccines & immunotherapeutics
Published: May 03, 2017
Development of gene therapies-lessons from nusinersen.
Journal: Gene therapy
Published: March 13, 2017
Association of immune globulin intravenous and thromboembolic adverse events.
Journal: American journal of hematology
Published: December 22, 2016
Showing 1-7 of 7
Last Updated: 09/26/2026